Preemptive DAAs for HCV+ Donor Livers Found Cost Effective

(MedPage Today) -- Direct-acting antiviral therapy in seronegative liver recipients could shorten transplant waiting lists
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news